Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Vycor Medical (VYCO) Shares Issued (2017)

Vycor Medical has reported Shares Issued over the past 6 years, most recently at -$822766.0 for Q4 2017.

  • Quarterly Shares Issued changed N/A to -$822766.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was -$822766.0 through Sep 2018, down 197.69% year-over-year, with the annual reading at $19441.0 for FY2017, N/A changed from the prior year.
  • Shares Issued was -$822766.0 for Q4 2017 at Vycor Medical, down from $842207.0 in the prior quarter.
  • Over five years, Shares Issued peaked at $4.1 million in Q1 2014 and troughed at -$822766.0 in Q4 2017.
  • The 3-year median for Shares Issued is $842207.0 (2017), against an average of $1.0 million.
  • The largest YoY upside for Shares Issued was 43.04% in 2013 against a maximum downside of 43.04% in 2013.
  • A 3-year view of Shares Issued shows it stood at $28481.0 in 2013, then skyrocketed by 3164.84% to $929860.0 in 2014, then crashed by 188.48% to -$822766.0 in 2017.
  • Per Business Quant, the three most recent readings for VYCO's Shares Issued are -$822766.0 (Q4 2017), $842207.0 (Q1 2017), and $929860.0 (Q2 2014).